Cohen & Steers, Inc.
NYSE:CNSAsset Management
+$0.63 today
- Market cap
- $3.45B
- Beta
- 1.23
- P/E (TTM)
- 24.8
- EPS (TTM)
- $3.03
- Dividend yield
- 3.44%
Volume 0.39M
Average 0.32M
CNS Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Cohen & Steers, Inc.NYSE: CNS
Operating Income · Q3 FY2026 · quarter ended Sep 2026
Operating income grows, but more slowly than its trailing trend
Q3 FY2026 operating income of $49.75M rose 1.7% year over year, behind the +11.5% change in trailing-twelve-month operating income. Sequentially, it fell 25.7% from the prior quarter. Over 3 fiscal years it compounded at -6.3% a year.
Context
- Operating income amounted to 31.3% of revenue in FY2025, down 2.1 pp from a year earlier.
- Operating income increased in 2 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 1 analysts of $228.69M (+28.7%) for the fiscal year ending Dec 2026, a step up from the +2.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $49.75M-25.7% QoQ
- Last fiscal yearDec 2025
- $177.74M+2.8% YoY
- LTMSep 2026
- $208.15M+11.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1.7% | +49.5% | +47.8 pp |
| 1 year | +2.8% | +28.7% | +25.9 pp |
| 3-year CAGR | -6.3% | +17.6% | +23.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 177.74M USD
- Year-over-year change
- +2.8%
- 4-year CAGR
- -9.1%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 177.74M | +2.8% |
| FY2024 | 2024-12-31 | 172.88M | +5.1% |
| FY2023 | 2023-12-31 | 164.48M | -23.8% |
| FY2022 | 2022-12-31 | 215.94M | -17.1% |
| FY2021 | 2021-12-31 | 260.37M | — |
Operating Income vs competitors
How CNS compares with its peers on the latest reported figures
- CNS's LTM Sep 2026 operating income of $208.15M is the 8th highest of the 10 companies compared; the peer median is $402M.
- Its year-over-year change of +11.5% is the 4th highest of 10, against a peer median of -13.9%.
- Operating income amounts to 33.9% of revenue for CNS, versus a peer median of 33.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $739.52M | +69.2% | +11.6% | 46.4% | |
| LTM Jun 2026 | $525.96M | +11.7% | +15.1% | 27.1% | |
| LTM Jun 2026 | $436.75M | +68.4% | +52.9% | 75.3% | |
| LTM Sep 2026 | $420.14M | +11.4% | +5.1% | 33.4% | |
| LTM Jun 2026 | $402M | -13.9% | -31.8% | 5.8% | |
| LTM Sep 2026 | $384.31M | -35.6% | -6.5% | 57.6% | |
| LTM Jun 2026 | $343.43M | -17.2% | +2.9% | 100.0% | |
| LTM Sep 2026 | $208.15M | +11.5% | -6.3% | 33.9% | |
| LTM Sep 2026 | $7M | -97.7% | +71.0% | 0.8% | |
| LTM Jun 2026 | -$16.97M | -142.3% | — | 3.7% | |
| Peer median (excluding CNS) | $402M | -13.9% | +8.4% | 33.4% | |
Competitors are the stored peer set for CNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 583.83M | 573.72M | 489.64M | 517.42M | 567.8M |
| Cost of Revenue | 271.33M | 291.76M | 254.35M | 275.12M | 241.28M |
| Gross Profit | 312.5M | 281.97M | 235.29M | 242.3M | 326.52M |
| Gross Margin | 53.5% | 49.1% | 48.1% | 46.8% | 57.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 48.03M | 54.83M | 66.7M | 60.14M | 71.23M |
| Operating Expenses | 52.13M | 66.03M | 70.81M | 69.42M | 148.78M |
| Depreciation & Amortization | 16.03M | 5.67M | 5.14M | 11.17M | 11.71M |
| EBITDA | 279.28M | 228.42M | 169.62M | 203.39M | 201.14M |
| EBITDA Margin | 47.8% | 39.8% | 34.6% | 39.3% | 35.4% |
| Operating Income | 260.37M | 215.94M | 164.48M | 172.88M | 177.74M |
| Operating Margin | 44.6% | 37.6% | 33.6% | 33.4% | 31.3% |
| Interest Income | 2.88M | 6.82M | 14.62M | 19.34M | 10.32M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 21.57M | (19.04M) | 15.77M | 36.66M | 26.89M |
| Income Before Tax | 281.94M | 196.9M | 180.25M | 209.54M | 204.63M |
| Pre-Tax Margin | 48.3% | 34.3% | 36.8% | 40.5% | 36.0% |
| Income Tax Expense | 55.79M | 47.41M | 43.64M | 46.75M | 47.23M |
| Net Income | 211.4M | 171.04M | 129.05M | 151.27M | 153.22M |
| Net Margin | 36.2% | 29.8% | 26.4% | 29.2% | 27.0% |
| EPS (Basic) | 4.38 | 3.51 | 2.62 | 3.00 | 2.99 |
| EPS (Diluted) | 4.31 | 3.47 | 2.60 | 2.97 | 2.98 |
| Weighted Avg Shares | 48.32M | 48.78M | 49.31M | 50.41M | 51.24M |
| Weighted Avg Shares (Diluted) | 49.09M | 49.3M | 49.55M | 50.94M | 51.64M |
Cohen & Steers, Inc.
NYSE:CNS
Intrinsic Alpha fair value
Locked
Current Price
$67.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.